Heart Rate Changes Following the Administration of Sugammadex

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03294018

Enrollment

276

Registered

2017-09-26

Start date

2017-09-06

Completion date

2019-01-10

Last updated

2019-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradycardia

Brief summary

This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decision is made to treat it, the medications and doses used will be recorded.

Interventions

OTHERRecording heart rate changes

Recording heart rate changes during planned sugammadex administration.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Inclusion criteria

* Patient age 0-18 years * Anesthetic plan includes NMB reversal with sugammadex

Exclusion criteria

* Sugammadex not used during the case

Design outcomes

Primary

Measure	Time frame
Bradycardia during sugammadex administration	intraoperative

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026